Premium Information is available for this item - Upgrade for $1 a day

6550-01-346-4790

Usp Blood Grouping Serum

6550013464790 013464790 F91H478 7-068

INC: 41243 Blood Grouping Serum

6550-01-346-4790 BLOOD GROUPING SERUM,USP 6550013464790 013464790

Managed by United States
NSN Created on 5 Oct 1991
Data Last Changed
January 2023
NATO Update Count
4
NATO Data Quality
6550-01-346-4790 BLOOD GROUPING SERUM,USP 6550013464790 013464790 1/1
NSN 6550-01-346-4790 (Generic Image) 1/1

6550-01-346-4790 Stock and Availability Marketplace 6550-01-346-4790

Need Help?
Request a Quotation from participating marketplace vendors

6550-01-346-4790 Related Documents Related Documents 6550-01-346-4790 5+ Documents (More...)

F91H478 7-068 Managed by United States NSN Created on 5 Oct 1991 Data Last Changed January 2023 NATO
RQST NE Updated Every Day 6550-01-346-4790 RQST Updated Every Day 6550-01-346-4790 RQST NE Related
Documents 6550-01-346-4790 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6550/us 6550
www.nsnlookup.com /fsg-65/fsc-6550/uk 6550-99-213-2824 https//www.nsnlookup.com /fsg-65/fsc-6550/us 6550-01-346-4790
Usp Blood Grouping Serum 6550013464790 fsg-65/fsc-6550/us 6550-01-346-4790 Usp Blood Grouping Serum
6550013464790 fsg-65/fsc-6550/uk 6550-99-213-2824 6550013288461 https//www.nsnlookup.com 6550013464790
6550 https/ Blood Grouping Serum 6550013288461 https//www.nsnlookup.com /fsg-65/fsc-6550/us 6550-01-346-4790
Usp Blood Grouping Serum 6550013464790 6550013464796 Usp Blood Grouping Serum 6550013464790 https
Grouping Serum 6550013288461 328-8461 Usp Blood Grouping Serum 6550013288461 https//www.nsnlookup.com 6550013464790
https//www.nsnlookup.com /fsg-65/fsc-6550/us 6550 https//www.nsnlookup.com /fsg-65/fsc-6550/us 6550-01-346-4790
Usp Blood Grouping Serum 6550013464790 https//www.nsnlookup.com /fsg-65/fsc-6550/us 6550 https/
-6550/us 6550-01- https//www.nsnlookup.com Serum 6550013288461 /fsc-6550/us 6550-01-346-4790 Usp 6550013288461
www.nsnlookup.com /fsg-65/fsc-6550/us 6550-01-267-2477 Usp Blood Grouping Serum 6550012672477 Grouping Serum 6550013464790
Grouping Serum 6550012672477 https//www.nsnlookup.com https//www.nsnlookup.com /fsg-65/fsc-6550/us 6550-01-346-4790
Usp Blood Grouping Serum 6550013464790 4790 https//www.nsnlookup.com /fsg-65/fsc-6550/us https/

6550-01-346-4790 Demil Restrictions 6550-01-346-4790

DEMIL: A | DEMILI: | CRITICALITY: X | HMIC: P | PMIC: A | EDC: | ADPEC:

6550-01-346-4790 is a Usp Blood Grouping Serum that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.

6550-01-346-4790 HTS and ScheduleB Import and Export 6550-01-346-4790

6550-01-346-4790 End Users End Users 6550-01-346-4790

MOE Rule:
V542
Effective Date:
1 Apr 1991

6550-01-346-4790 Manufacturers Approved Sources 6550-01-346-4790

6550-01-346-4790 Technical Data Datasheet 6550-01-346-4790

Characteristic
Specifications
FIIG
A10000
Physical Form [AGXW]
Liquid
Type Designation [ATEJ]
Anti-C3 (C3b And C3d)
Primary Container Type [CQCT]
Bottle
Primary Container Content Quantity [CRLK]
5.000 Milliliters

6550-01-346-4790 Management Data Management Data 6550-01-346-4790

Effective Date
Organization
Unit of Issue
Unit Price
Qty Unit Pack
Feb 1992
Veterans Administration (VA)
VI
Subscribe
1

6550-01-346-4790 Similar Items Similar Supply Items to 6550-01-346-4790

6550-01-346-4790 Freight Data Freight Information 6550-01-346-4790

6550-01-346-4790 has freight characteristics managed by the Bonneville Power Administration.. 6550-01-346-4790 has a variance between NMFC and UFC when transported by rail and the description should be consulted.